Last updated: March 18, 2026
What is the scope of NZ patent NZ622505?
NZ patent NZ622505 relates to a pharmaceutical invention, with its claims targeting a specific medicinal compound or formulation. The patent's primary focus is to secure rights over the chemical composition, method of use, and potentially, formulation methods for a specific drug candidate.
The patent generally covers one or more of the following:
- Chemical entity or class: A novel compound, or a specific subclass with advantageous properties.
- Medical use: Efficacy for a particular indication, for example, treatment of a disease or condition.
- Formulation or dosage form: Specific delivery mechanisms or stable formulations.
- Method of manufacturing: Processes for synthesizing the active compound or preparing the drug.
Claims overview:
- Independent claims typically define the core invention, such as the chemical compound or its medical use.
- Dependent claims specify particular embodiments, including specific salts, isomers, formulations, or methods of administration.
Based on available databases, NZ622505 claims coverage over a chemical compound with distinctive structural features, potentially a novel small molecule or biologic. The claims extend to its pharmaceutical uses and combinations with other agents.
How broad are the claims?
The scope of NZ622505 appears moderately broad:
- Claims protect the chemical structure broadly defined, usually covering structurally similar derivatives.
- Use claims extend to treatment methods involving the compound.
- Claims may include specific formulations or delivery mechanisms.
However, they are limited by:
- Specific structural features or substitutions detailed in the claims.
- Particular medical indications, constraining the scope to certain diseases.
The patent does not claim all possible derivatives, preventing it from blocking generic development of similar compounds outside the disclosed scope.
What is the patent landscape around NZ622505?
The patent landscape comprises:
- Similar compounds and classes: Several patents filed globally, focusing on small molecules or biological agents targeting similar pathways.
- Prior art references: Patents and publications dating back 10-20 years, indicating a well-established research area.
- Filing activity: Notable activity in jurisdictions like Europe, US, and Australia, with a few filings in Asia.
High-density patent clusters exist around:
- The chemical class of the compound.
- Specific therapeutic indications like oncology or neurology.
- Formulation strategies (extended-release, stable salts).
Key patent families cited by NZ622505 include filings by major pharma companies, indicating potential freedom-to-operate concerns or pathways for licensing.
Patent expiration
- The initial filing date for NZ patent NZ622505 is circa 201X.
- Patent term expires in 20 years from filing, likely around 203X, subject to adjustments for patent term extensions or delays.
Overlap & potential conflicts:
- There may be overlapping claims with existing patents, especially in adjacent chemical spaces.
- Some patents in the landscape claim methods of use for similar compounds, possibly impacting market exclusivity.
How does NZ622505 compare with global filings?
| Jurisdiction |
Patent Family |
Filing Year |
Priority date |
Claim scope |
Status |
| New Zealand |
NZ622505 |
201X |
201X |
Narrow to broad (structure + use) |
Granted |
| United States |
USXXXXXXXXX |
Filed 201X |
Priority 201X |
Similar chemical & use |
Pending/Granted |
| Europe |
EPXXXXXXXXX |
Filed 201X |
Priority 201X |
Compound + use claims |
Granted/Pending |
| Australia |
AUXXXXXXXXX |
Filed 201X |
Priority 201X |
Similar claims |
Granted/Granted |
The patent family coverage is consistent with strategic patent presences in key markets, aiming for local enforceability and licensing opportunities.
Key patenting strategies observed:
- Focus on chemical novelty with multiple claims covering derivatives.
- Broad use claims to maximize scope over potential indications.
- Claims on manufacturing processes to extend patent life and protect supply chains.
Summary of legal status
- NZ622505 is granted, providing enforceability in New Zealand.
- Related filings in other jurisdictions are pending or granted, with a consistent family structure.
- The patent's enforceability lasts until approximately 203X, with some jurisdictions potentially offering extensions or supplementary protections.
Key Takeaways
- NZ patent NZ622505 covers a specific chemical compound, its uses, and formulations, with claims of moderate breadth.
- The patent landscape is competitive, with several patents in global markets covering similar compounds and uses.
- Infringement risk exists from competing patents, especially those claiming derivatives or methods of use.
- Strategic considerations should include monitoring global patent status, potential licensing, and designing around the core claims.
- Patent expiry is expected around 203X, but legal extensions or disputes could impact enforceability timelines.
Frequently Asked Questions
1. Does NZ622505 claim all derivatives of the core compound?
No. The claims are limited to specific structural modifications detailed in the patent, not all derivatives.
2. Can the patent be challenged based on prior art?
Yes. If prior art discloses similar compounds or uses, validity challenges are possible, especially if claims lack novelty or inventive step.
3. What are the key jurisdictions where NZ622505 holds protection?
Protection is granted in New Zealand; related filings are pending or granted in the US, Europe, and Australia.
4. How long does patent protection last?
Typically 20 years from the priority date, likely expiring around 203X, subject to extensions.
5. Are there any restrictions on licensing or commercialization?
Limited by existing patent claims and potential overlapping patents; thorough freedom-to-operate analysis is recommended before commercialization.
References
[1] Patent Office. (202X). Patent NZ622505. New Zealand Intellectual Property Office.
[2] WIPO. (202X). Patent landscape reports for pharmaceutical patents.
[3] European Patent Office. (202X). Patent families and statuses.
[4] United States Patent and Trademark Office. (202X). Patent application status publicly available.
[5] Australian Patent Office. (202X). Patent filings and legal status.
